CTOs on the Move

Circle Cardiovascular Imaging

www.circlecvi.com

 
Circle Cardiovascular Imaging is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.circlecvi.com
  • 12-3535 Research Rd NW
    Calgary, AB CAN T2L 2K8
  • Phone: 403.338.1870

Executives

Name Title Contact Details

Funding

Circle Cardiovascular Imaging raised $16M on 05/15/2018

Similar Companies

HumanTouch

Human Touch is the leading provider of high-quality, innovative lifestyle products, massage chairs, and experiences that deliver life-changing benefits. We have been making people feel better for over 35 years by developing state-of-the-art massage products containing patented massage systems that replicate techniques used by massage professionals. Our wellness solutions help to reduce muscle tension and pain caused by today`s hectic lifestyle so that people can do what they do - better. Combining advanced technology and attractive design, Human Touch innovations are perfectly suited for today`s modern and traditional living spaces. Our customers include serious athletes looking to recover from intensive training, thousands of chiropractors who integrate a therapeutic massage on a Human Touch massage chair into their professional services, back pain sufferers looking to reduce their aches and pains, and everyday people looking for a respite from the stress of today`s lifestyle.

Flugen

FluGen is driving the development of a universal flu vaccine to advance human health.

Vertebral Technologies

Vertebral Technologies, Inc. is a Minnetonka, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Mectra Labs

Mectra Labs is a Bloomfield, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.